Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Aethlon Medical Inc | AEMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.53 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.35 - 5.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.53 | USD |
Aethlon Medical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.01M | 2.62M | - | 574k | -12.03M | -4.59 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Aethlon Medical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.40 | 1.55 | 1.40 | 1.48 | 7,970 | 0.13 | 9.29% |
1 Month | 1.73 | 1.77 | 1.35 | 1.58 | 8,152 | -0.20 | -11.56% |
3 Months | 1.78 | 1.88 | 1.35 | 1.67 | 8,169 | -0.25 | -14.04% |
6 Months | 1.55 | 2.3499 | 1.35 | 1.87 | 13,908 | -0.02 | -1.29% |
1 Year | 4.30 | 5.00 | 1.35 | 3.58 | 128,155 | -2.77 | -64.42% |
3 Years | 19.10 | 124.90 | 1.35 | 46.78 | 1,271,078 | -17.57 | -91.99% |
5 Years | 8.161 | 124.90 | 1.35 | 38.51 | 1,170,464 | -6.63 | -81.25% |
Aethlon Medical Description
Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment. |